Supplementary Material from Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)
Abstract
Supplementary Material from Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancerKeywords
This publication has 0 references indexed in Scilit: